title: Secukinumab for ankylosing spondylitis--authors' reply.
authors.affiliation: Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
authors.forename: Dominique
authors.initials: D
authors.lastname: Baeten
authors.affiliation: Translational Medicine-Autoimmunity, Novartis Institutes for BioMedical Research WSJ.386.10.48, Basel CH-4002, Switzerland. Electronic address: wolfgang.hueber@novartis.com.
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Hueber
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents